









Markets
/
Stocks
/
nasdaq-rapp
/

Rapport Therapeutics Inc

RAPP

27.350USD

+1.050+3.99%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

998.21MMarket Cap

LossP/E TTM



Rapport Therapeutics Inc

27.350

+1.050+3.99%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-53.31%-25.07M

-14.89%-20.24M

-39.48%-14.45M

-202.64%-16.41M

-147.80%-16.35M

-266.90%-17.61M

---10.36M

---5.42M

---6.60M

---4.80M

Net income from continuing operations

-47.52%-26.73M

-6.15%-24.06M

-47.79%-19.98M

-101.37%-17.54M

-182.65%-18.12M

-268.78%-22.67M

---13.52M

---8.71M

---6.41M

---6.15M

Operating gains losses

21.15%252.00K

60.53%244.00K

390.57%260.00K

852.17%219.00K

890.48%208.00K

913.33%152.00K

--53.00K

--23.00K

--21.00K

--15.00K

Other non-cash items

158.36%391.00K

-100.38%-25.00K

319.08%725.00K

-1614.29%-1.80M

---670.00K

537.67%6.57M

--173.00K

--119.00K

--0.00

--1.03M

Change in working capital

-2639.84%-3.37M

86.28%-433.00K

-31.02%1.34M

-120.88%-477.00K

89.34%-123.00K

-648.10%-3.16M

--1.94M

--2.28M

---1.15M

---422.00K

-Change in prepaid expenses

-579.89%-4.32M

60.14%-825.00K

99.36%-12.00K

-232.28%-672.00K

173.95%900.00K

-241.58%-2.07M

---1.89M

--508.00K

---1.22M

---606.00K

-Change in other current assets

-2170.83%-497.00K

-288.89%-51.00K

127.83%32.00K

-100.00%0.00

4.35%24.00K

115.70%27.00K

---115.00K

--24.00K

--23.00K

---172.00K

Cash from non-recurring investing activities

Cash from operating activities

-53.31%-25.07M

-14.89%-20.24M

-39.48%-14.45M

-202.64%-16.41M

-147.80%-16.35M

-266.90%-17.61M

---10.36M

---5.42M

---6.60M

---4.80M

Investing cash flow

Net cash from continuing investing activities

-97.72%22.00K

-72.85%291.00K

-84.27%226.00K

169.23%140.00K

1024.42%967.00K

1657.38%1.07M

--1.44M

--52.00K

--86.00K

--61.00K

Capital expenditures

-97.72%22.00K

-72.85%291.00K

-84.27%226.00K

169.23%140.00K

1024.42%967.00K

1657.38%1.07M

--1.44M

--52.00K

--86.00K

--61.00K

Net cash flow from disposal of fixed assets

-97.72%22.00K

-72.85%291.00K

-84.27%226.00K

169.23%140.00K

1024.42%967.00K

1657.38%1.07M

--1.44M

--52.00K

--86.00K

--61.00K

Net cash flow from investment products

121.31%22.62M

152.19%21.32M

141.64%32.16M

---52.90M

---106.14M

---40.85M

---77.22M

----

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

121.10%22.60M

150.16%21.03M

140.59%31.93M

-101901.92%-53.04M

-124439.53%-107.10M

-68631.15%-41.93M

---78.66M

---52.00K

---86.00K

---61.00K

Financing cash flow

Cash flow from continuous financing activities

-100.04%-63.00K

-99.99%5.00K

105.00%7.00K

-101.63%-1.39M

177158.89%159.35M

6.09%63.66M

---140.00K

--85.36M

---90.00K

--60.01M

Net cash flow from common stock issuance/repurchase

-100.00%0.00

---1.00K

100.00%0.00

-2681.48%-1.39M

530133.33%159.07M

-100.00%0.00

---6.00K

--54.00K

--30.00K

--24.00K

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--0.00

-100.00%0.00

----

--63.94M

----

--85.31M

----

--0.00

Proceeds from stock option exercised by employees

--0.00

--6.00K

--7.00K

----

Net cash flow from other financing activities

-122.26%-63.00K

100.00%0.00

----

335.83%283.00K

-100.47%-283.00K

---134.00K

--0.00

---120.00K

--59.98M

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.04%-63.00K

-99.99%5.00K

105.00%7.00K

-101.63%-1.39M

177158.89%159.35M

6.09%63.66M

---140.00K

--85.36M

---90.00K

--60.01M

Net cash flow

Beginning cash balance

-22.40%57.71M

-18.99%56.91M

-75.27%39.42M

38.65%110.27M

-13.82%74.37M

125.47%70.25M

--159.41M

--79.53M

--86.30M

--31.16M

Current period cash flow changes

-107.07%-2.54M

-80.60%799.00K

119.62%17.49M

-188.69%-70.85M

629.85%35.90M

-92.53%4.12M

---89.16M

--79.88M

---6.78M

--55.14M

Ending cash balance

-49.97%55.17M

-22.40%57.71M

-18.99%56.91M

-75.27%39.42M

38.65%110.27M

-13.82%74.37M

--70.25M

--159.41M

--79.53M

--86.30M

Free cash flow

-44.88%-25.09M

-9.85%-20.53M

-24.40%-14.67M

-202.32%-16.55M

-159.07%-17.32M

-284.35%-18.69M

---11.79M

---5.48M

---6.69M

---4.86M

Currency unit

USD

Audit opinions

KeyAI

